Semaglutide ml to mg: Reading Your Wegovy Dose Correctly

The misconception worth clearing up first: ml is not the dose

A common worry among people starting Wegovy is that they need to match the ml markings on the pen to their prescribed dose. They do not. Milligrams measure how much active semaglutide is in the injection; millilitres measure the total volume of liquid used to carry it. The two are related but not interchangeable, and the ratio shifts between different pen strengths.

For context: Novo Nordisk's pre-filled Wegovy pens contain semaglutide dissolved in a solution at a set concentration. At the 0.25 mg and 0.5 mg strengths, the injection volume is 0.5 ml; at higher strengths the volume is typically 1 ml. So a 1.7 mg dose and a 2.4 mg dose both involve 1 ml of fluid, yet they contain meaningfully different amounts of semaglutide. If you tried to use the ml figure to work out your mg dose, you would reach the wrong answer at most strengths. The NHS medicines page for semaglutide is clear that dosing is always discussed in mg, and the pen label will show the mg strength on the cartridge itself.

The practical upshot is simple: you do not need to calculate anything. The pen is pre-set. Press the button, the correct mg dose is delivered. If you want a closer look at how the volume side of this works in practice, the semaglutide dose in ml guide on this site walks through each pen strength in detail.

How the licensed mg schedule actually runs, and what drives each step

Understanding the mg ladder helps make sense of why the ml volume question arises in the first place. Wegovy's starting dose is 0.25 mg once weekly. That is not a therapeutic dose in the sense of producing significant weight loss; its job is to let your body adjust to the medicine before the dose increases. From there, a prescriber typically moves the dose up roughly every four weeks: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg. The 2.4 mg weekly injection has been the standard licensed maintenance dose since Wegovy's UK approval.

In January 2026, the MHRA approved an additional 7.2 mg maintenance dose for adults with obesity, initially supplied as three 2.4 mg pens taken in a single week, with a dedicated single-dose 7.2 mg pen approved on 14 April 2026 for BMI 30 or above. The full breakdown of Wegovy doses covers each step and what the clinical evidence says about outcomes at each level. Crucially, the speed and ceiling of titration is a clinical decision, your prescriber reviews your response and tolerance before any increase.

People searching for specific mg figures often land on pages about the 1 mg semaglutide dose or the 0.5 mg pen and worry these numbers correspond to ml they should measure themselves. They do not. Every step on the schedule is delivered as a pre-set injection.

Rybelsus tablets: semaglutide in mg by a different route

The ml-to-mg confusion intensifies when people encounter oral semaglutide, because tablet strengths are expressed purely in mg with no volume dimension at all. There are two oral semaglutide products, and they are not interchangeable. Rybelsus (3 mg, 7 mg, 14 mg tablets) is licensed for type 2 diabetes management, not weight loss. If you have come across a reference to 3 mg semaglutide or 7 mg semaglutide tablets and wondered whether these are weight-loss doses, they are Rybelsus strengths and are outside the weight-loss licence entirely.

Wegovy tablets (approved by the MHRA on 11 June 2026, the first oral GLP-1 medicine licensed for weight management in the UK) follow a completely separate schedule: 1.5 mg, 4 mg, 9 mg, and 25 mg maintenance. Those strengths belong only to the Wegovy tablet; do not map them across to injection doses. For anyone weighing up which form might suit them, our Wegovy overview explains both presentations side by side. If you are specifically curious about what 5 mg of semaglutide refers to in various contexts, that page clarifies the distinction.

Storing your pen and staying on the right dose

One practical point patients sometimes overlook: the pen that has been sitting in the fridge door since your last dose is the authority on your current mg strength, not a number you recall from a conversation or a forum post. The label on the cartridge confirms the strength. Wegovy pens are stored refrigerated at 2–8°C; once in use, the pen may be kept at room temperature for a limited period, the exact window is in the Patient Information Leaflet in your box, and that is where you should check it, not a third-party source.

If you are reviewing the cost of ongoing treatment, the Wegovy pricing and access page sets out what a full private prescription service includes. And if you have questions about a dose your prescriber has suggested (including whether micro-dosing Wegovy is ever clinically appropriate) those are exactly the conversations a prescriber should lead, not something to resolve from a dose-conversion table online. The NICE appraisal of semaglutide for weight management (NICE TA875) underpins how prescribers assess eligibility and ongoing treatment decisions in the UK.

If you would like to discuss your current dose or explore whether Wegovy is suitable for you, speak to our prescribers through a free consultation, a real clinician reviews your answers the same day.